Update Breast Cancer 2023 Part 2 - Advanced-Stage Breast Cancer

Michael P Lux1, Andreas D Hartkopf2, Tanja N Fehm3

  • 1Klinik für Gynäkologie und Geburtshilfe, Frauenklinik St. Louise, Paderborn, St. Josefs-Krankenhaus, Salzkotten, St. Vincenz Krankenhaus GmbH, Paderborn, Germany.

PubMed

Insights

New therapies, including CDK4/6 inhibitors and antibody drug conjugates (ADCs), are improving outcomes for advanced breast cancer patients. Recent studies show significant potential to change treatment paradigms and improve survival rates.

Area of Science:

  • Oncology
  • Medical Therapeutics
  • Clinical Research

Background:

  • Advanced breast carcinoma treatment has seen recent therapeutic advancements.
  • Key emerging therapies include CDK4/6 inhibitors, oral selective estrogen receptor degraders, antibody drug conjugates (ADCs), and PARP inhibitors.
  • These agents aim to overcome endocrine resistance and improve patient outcomes.

Purpose of the Study:

  • To review and evaluate recent study results on novel therapies for advanced breast carcinoma.
  • To assess the impact of new treatments on the therapeutic landscape.
  • To highlight ongoing developments in breast cancer therapy.

Main Methods:

  • Review of recently published clinical study results.
  • Analysis of overall survival data from key trials.
  • Evaluation of treatment comparisons and efficacy in specific settings.

Main Results:

  • Destiny-Breast03 study demonstrated significant overall survival data.
  • CAPItello-291 and Serena-2 studies presented initial analyses.
  • RIGHT Choice study compared CDK4/6 inhibitors with chemotherapy in first-line therapy.
  • Destiny-Breast02 study provided first analysis post-T-DM1 treatment.

Conclusions:

  • Recent studies indicate significant potential to alter the treatment of advanced breast carcinoma.
  • The rapid development of novel therapies continues to yield promising new results.
  • These advancements offer new hope and improved therapeutic options for patients.

Related Concept Videos

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.7K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K
Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
357
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
380